23
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TNU0419 |
2’-Deoxy-N6-methyl adenosine
|
||
Nucleoside Derivatives - N-Methylated nucleosides; Drugs and Inhibitors; antitumor and differentiation agent bacterial nucleoside; methylated adduct of DNA, antimalarial agent | |||
T75033 | Adenosine-2-carboxy methyl amide | ||
Adenosine-2-carboxy methyl amide为一种嘌呤核苷类似物,其抗肿瘤活性广泛,尤其针对惰性淋巴系统恶性肿瘤。其作用机制主要通过抑制DNA合成及诱导细胞凋亡(apoptosis)实现。 | |||
TNU0554 |
N1-Methyl-2’-beta-C-methyl adenosine
|
||
N1-Methyl-2'-beta-C-methyl adenosine is a Nucleoside Derivative - 2'-Modified nucleoside; N-Methylated alkylated nucleoside. | |||
T75056 | N1-Methyl-2’-beta-C-methyl adenosine | ||
N1-Methyl-2’-beta-C-methyl adenosine 是一种具有广泛抗肿瘤活性的嘌呤核苷类似物,主要靶向惰性淋巴系统恶性肿瘤。其抗癌机制主要通过抑制 DNA 合成和诱导细胞凋亡 (apoptosis) 实现。 | |||
TNU0587 |
8-Chloro-2’-O-methyl adenosine
|
||
Nucleoside Derivatives - Halo-nucleosides, 8-Modified purine nucleosides, 2’-modified nucleosides | |||
TNU0559 |
N1-Methyl-2’-O-(2-methoxyethyl) adenosine
|
||
N1-Methyl-2'-O-(2-methoxyethyl) adenosine is a Nucleoside Derivative - 2'-Modified nucleoside, N-Methylated/ alkylated nucleoside. | |||
T75062 | N6-Methyl-2’-O-(2-methoxyethyl) adenosine | ||
N6-Methyl-2’-O-(2-methoxyethyl) adenosine 为嘌呤核苷类似物,具备广泛抗肿瘤活性,主要靶向惰性淋巴系统恶性肿瘤。其抗癌机制涉及抑制 DNA 合成及诱导细胞凋亡(apoptosis)。 | |||
TNU0560 |
N6-Methyl-2’-O-(2-methoxyethyl) adenosine
|
||
N6-Methyl-2'-O-(2-methoxyethyl) adenosine is a Nucleoside Derivative - 2'-Modified nucleoside, 6-Modified purine nucleoside. | |||
TNU0297 |
Adenosine-2-carboxylic acid methyl ester
|
||
Adenosine-2-carboxylic acid methyl ester is a Nucleoside Derivative - 2-Modified purine nucleoside. | |||
T75061 | N1-Methyl-2’-O-(2-methoxyethyl) adenosine | ||
N1-Methyl-2’-O-(2-methoxyethyl) adenosine 是一种具有广泛抗肿瘤活性的嘌呤核苷类似物,主要靶向惰性淋巴系统恶性肿瘤。其机制主要依赖于抑制DNA合成及诱导细胞凋亡(apoptosis)。 | |||
TNU1524 |
2-(3-Methyl-n-butylidenehydrazino) adenosine
|
||
2-(3-Methyl-n-butylidenehydrazino) adenosine is a Nucleoside Derivative - 2-Modified purine nucleoside. | |||
TNU0585 |
N6-Methyl-2’-beta-C-ethynyl adenosine
|
||
N6-Methyl-2'-beta-C-ethynyl adenosine is a Nucleoside Derivative - 2'-Modified nucleoside, 6-Modified purine nucleoside. | |||
TNU0462 |
N6-(3-Methoxybenzyl)-2’-C-methyl adenosine
|
||
N6-(3-Methoxybenzyl)-2'-C-methyl adenosine is a Nucleoside Derivative - 6-Modified purine nucleoside; 2'-Modified nucleoside. | |||
TNU0563 |
N1-Methyl-3’-O-(2-methoxyethyl) adenosine
|
||
N1-Methyl-3'-O-(2-methoxyethyl) adenosine is a Nucleoside Derivative - 3'-Modified nucleoside, N-Methylated/ alkylated nucleoside. | |||
T75069 | N6-Methyl-2’-beta-C-ethynyl adenosine | ||
N6-Methyl-2’-beta-C-ethynyl adenosine 是一种嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性,靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制 DNA 合成,诱导细胞凋亡 (apoptosis) 等。 | |||
TNU0463 |
N6-(4-Methoxybenzyl)-2’-C-methyl adenosine
|
||
N6-(4-Methoxybenzyl)-2'-C-methyl adenosine is a Nucleoside Derivative - 6-Modified purine nucleoside; 2'-Modified nucleoside. | |||
T75063 | N1-Methyl-3’-O-(2-methoxyethyl) adenosine | ||
N1-Methyl-3’-O-(2-methoxyethyl) adenosine是一种具有广泛抗肿瘤活性的嘌呤核苷类似物,主要针对惰性淋巴系统恶性肿瘤。其抗癌机制包括抑制DNA合成和诱导细胞凋亡(apoptosis)等作用。 | |||
TNU0458 |
N6-(3-Trifluoromethylbenzyl)-2’-C-methyl adenosine
|
||
N6-(3-Trifluoromethylbenzyl)-2'-C-methyl adenosine is a Nucleoside Derivative - 6-Modified purine nucleoside; 2'-Modified nucleoside. | |||
TNU0564 |
N6-Methyl-3’-O-(2-methoxyethyl) adenosine
|
||
N6-Methyl-3'-O-(2-methoxyethyl) adenosine is a Nucleoside Derivative - 3'-Modified nucleoside, 6-Modified purine nucleoside. | |||
TNU1618 |
5'-O-DMTr-2'-O-methyl-N6-methyl adenosine 3'-CED phosphoramidite
|
||
5'-O-DMTr-2'-O-methyl-N6-methyl adenosine 3'-CED phosphoramidite is a Nucleoside Phosphoramidite. | |||
TNU1364 |
2-Amino-3’,5’-di-O-acetyl-N6,N6-dimethyl-2’-O-methyl adenosine
|
||
2-Amino-3',5'-di-O-acetyl-N6,N6-dimethyl-2'-O-methyl adenosine is a Nucleoside Derivative - 6-Modified purine nucleoside; 2'-Modified nucleoside. | |||
T50029 |
G6Pase catalytic subunit 1 inhibitor 1
2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine,2-[(1E)-(dibenzylhydrazin-1-ylidene)methyl]pyridine |
Others | Others |
2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine (2-[(1E)-(dibenzylhydrazin-1-ylidene)methyl]pyridine) 是一种杂环化合物。它可以抑制单胺氧化酶,导致体内单胺水平升高;也可以抑制腺苷脱氨酶,导致体内腺苷水平升高;还可以可以增加某些神经递质的活性,包括血清素和多巴胺。 | |||
T26266 |
TH-162
L-PIA,(R)-PIA,(R)- PIA,(R)-PIA,L-2-N6-(Phenylisopropyl)adenosine |
||
TH-162, also known as (R)-PIA and Adenosine, N-(1-methyl-2-phenylethyl)-, (R)-, is an agonist of the A1 adenosine receptor. Affinity for adenosine receptors is approx. 100× that of the (+)-isomer. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN7208 |
2-Methyladenosine
2-methyl adenosine,2-甲基腺苷 |
Others | Others |
2-Methyladenosine (2-methyl adenosine) 是一种海洋来源的天然产物,存在于Family Tethyidae。 |